| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 31, 2006
From the Departments of Medicine/Cardiology Division (J.Z., J.M., S.Y.), Cardiovascular Research Institute (L.P., C.H., P.K.), Epidemiology and Biostatistics (C.M.), Neurology (N.K., W.S.), Neurosurgery (M.L.), and The Center for Cerebrovascular Research, Department of Anesthesia and Perioperative Care (A.A., W.Y.), University of California, San Francisco. * To whom correspondence should be addressed. E-mail: zaroff{at}medicine.ucsf.edu.
Background and Purpose--Cardiac abnormalities occur commonly after subarachnoid hemorrhage (SAH) and may be caused by excessive release of catecholamines from the myocardial sympathetic nerves. We hypothesized that adrenoceptor polymorphisms resulting in greater catecholamine sensitivity would be associated with an increased risk of cardiac injury. Methods--This was a prospective cohort study. The primary outcome variables were the serum level of cardiac troponin I (cTi, abnormal if >1.0 µg/L) and the left ventricular ejection fraction (LVEF, abnormal if <50%). Six adrenoceptor polymorphisms were genotyped: Results--The study included 182 patients. The CC genotype (Arg/Arg) of Conclusions--Genetic polymorphisms of the adrenoceptors are associated with an increased risk of cardiac abnormalities after SAH. These data support the hypothesis that cardiac dysfunction after SAH is a form of neurocardiogenic injury.
Accepted on April 10, 2006
Adrenoceptor Polymorphisms and the Risk of Cardiac Injury and Dysfunction After Subarachnoid Hemorrhage
Jonathan G. Zaroff MD*;
1AR Arg389Gly,
1AR Ser49Gly,
2AR Gly16Arg,
2AR Gln27Glu,
2AR Thr164Ile, and
2AR del322-325. The effect of each polymorphism on the risk of developing cardiac abnormalities was quantified using multivariable logistic regression.
1AR Arg389Gly (odds ratio [OR] 3.4, P=0.030) and the CC genotype (Gln/Gln) of
2AR Gln27Glu (OR 3.1, P=0.032) were predictive of cTi release. The presence of the
2AR deletion was predictive of reduced LVEF (OR 4.2, P=0.023). The combination of the
1AR 389 CC and the
2AR 27 CC genotypes resulted in a marked increase in the odds of cTi release (OR 15.5, P=0.012). The combination of the
1AR 389 CC and the
2AR deletion genotypes resulted in a marked increase in the odds of developing a reduced LVEF (OR 10.3, P=0.033).
Related Article:
Stroke 2006 37: 1635.
This article has been cited by other articles:
![]() |
R. Ramaraj Stress cardiomyopathy: aetiology and management Postgrad. Med. J., August 1, 2007; 83(982): 543 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Atanassova Previous Cardiac Abnormalities in Subarachnoid Hemorrhage May Also Have Background Genetic Polymorphisms Stroke, December 1, 2006; 37(12): 2872 - 2872. [Full Text] [PDF] |
||||
![]() |
A. M. Naidech Adrenoreceptor Polymorphisms and Subarachnoid Hemorrhage Stroke, July 1, 2006; 37(7): 1635 - 1635. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |